The role of Continuous Glucose Monitoring is growing in diabetes management – and Dexcom aims to be the frontrunner in the space. The San Diego, CA-based company has its G7 CGM on the horizon; solid studies that were presented at the American Diabetes Association 81^st Scientific Sessions; diabetes driving telemedicine; and even that Super Bowl Commercial collaboration with Nick Jonas.

Dexcom’s CEO Kevin Sayer checks in for this episode of Let’s Talk Medtech and discusses the company’s recent activities and paints a picture of what the future of CGM will look like.